Janone Inc. (NASDAQ:ALTS) Sees Significant Drop in Short Interest

Janone Inc. (NASDAQ:ALTS) was the target of a large decline in short interest in November. As of November 30th, there was short interest totalling 80,700 shares, a decline of 37.3% from the November 15th total of 128,800 shares. Based on an average daily trading volume, of 178,800 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.6% of the shares of the stock are sold short.

Janone Trading Up 10.1 %

Shares of ALTS opened at $3.92 on Friday. Janone has a twelve month low of $0.46 and a twelve month high of $5.26. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 1.96. The firm’s 50-day moving average is $2.41.

Janone Company Profile

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.